A LinkedIn post from Segmed highlights that co‑founder and Chief Scientific Officer Martin Willemink is chairing a session at the 2026 IEEE International Symposium on Biomedical Imaging in London. The session focuses on preparing large‑scale medical imaging data for foundation model development, with contributions from academic and industry groups across the U.S., Europe, and China.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests Segmed is positioning itself at the center of discussions on data quality, diversity, and responsible sourcing for medical imaging AI. For investors, this visibility among leading research institutions and companies such as GE HealthCare may reinforce Segmed’s credibility as a data and AI partner, potentially supporting future commercialization, collaborations, and competitive positioning in medical imaging infrastructure.

